Ignite Creation Date:
2025-12-24 @ 5:14 PM
Ignite Modification Date:
2025-12-25 @ 2:51 PM
Study NCT ID:
NCT03454750
Status:
COMPLETED
Last Update Posted:
2025-01-08
First Post:
2018-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)
Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-27
First Submit QC Date:
None
Study First Post Date:
2018-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-07
Last Update Post Date:
2025-01-08
Last Update Post Date Type:
ACTUAL